Early recurrence in standard-risk medulloblastoma patients with the common idic(17)(p11.2) rearrangement
Authors:
- G. A. Bien-WillnerGBG. A. Bien-Willner
- D. Lopez-TerradaDLD. Lopez-Terrada
- M. B. BhattacharjeeMBM. B. Bhattacharjee
- K. U. PatelKPK. U. Patel
- P. StankiewiczPSP. Stankiewicz
- J. R. LupskiJLJ. R. Lupski
- J. D. PfeiferJPJ. D. Pfeifer
- A. PerryAPA. Perry
- 9 May 2012
- journal article
- Published by Oxford University Press (OUP) in Neuro-Oncology
- Vol. 14 (7) , 831-840
Abstract
Medulloblastoma is diagnosed histologically; treatment depends on staging and age of onset. Whereas clinical factors identify a standard- and a high-risk population, these findings cannot differentiate which standard-risk patients will relapse and die. Outcome is thought to be influenced by tumor subtype and molecular alterations. Poor prognosis has been associated with isochromosome (i)17q in some but not all studies. In most instances, molecular investigations document that i17q is not a true isochromosome but rather an isodicentric chromosome, idic(17)(p11.2), with rearrangement breakpoints mapping within the REPA/REPB region on 17p11.2. This study explores the clinical utility of testing for idic(17)(p11.2) rearrangements using an assay based on fluorescent in situ hybridization (FISH). This test was applied to 58 consecutive standard- and high-risk medulloblastomas with a 5-year minimum of clinical follow-up. The presence of i17q (ie, including cases not involving the common breakpoint), idic(17)(p11.2), and histologic subtype was correlated with clinical outcome. Overall survival (OS) and disease-free survival (DFS) were consistent with literature reports. Fourteen patients (25%) had i17q, with 10 (18%) involving the common isodicentric rearrangement. The presence of i17q was associated with a poor prognosis. OS and DFS were poor in all cases with anaplasia (4), unresectable disease (7), and metastases at presentation (10); however, patients with standard-risk tumors fared better. Of these 44 cases, tumors with idic(17)(p11.2) were associated with significantly worse patient outcomes and shorter mean DFS. FISH detection of idic(17)(p11.2) may be useful for risk stratification in standard-risk patients. The presence of this abnormal chromosome is associated with early recurrence of medulloblastoma.Keywords
This publication has 49 references indexed in Scilit:
- Molecular subgroups of medulloblastoma: the current consensusActa Neuropathologica, 2011
- Definition of Disease-Risk Stratification Groups in Childhood Medulloblastoma Using Combined Clinical, Pathologic, and Molecular VariablesJournal of Clinical Oncology, 2011
- Medulloblastoma: clinicopathological correlates of SHH, WNT, and non-SHH/WNT molecular subgroupsActa Neuropathologica, 2011
- Copy number variation at the breakpoint region of isochromosome 17qGenome Research, 2008
- Medulloblastoma: tumorigenesis, current clinical paradigm, and efforts to improve risk stratificationNature Clinical Practice Oncology, 2007
- Isochromosome 17q Is a Negative Prognostic Factor in Poor-Risk Childhood Medulloblastoma PatientsClinical Cancer Research, 2005
- Combined Histopathological and Molecular Cytogenetic Stratification of Medulloblastoma PatientsClinical Cancer Research, 2004
- Medulloblastomas With Favorable Versus Unfavorable Histology: How Many Small Blue Cell Tumor Types are There in the Brain?Advances in Anatomic Pathology, 2002
- Somatic mutations ofWNT/wingless signaling pathway components in primitive neuroectodermal tumorsInternational Journal of Cancer, 2001
- Isochromosome 17q in primitive neuroectodermal tumors of the central nervous systemGenes, Chromosomes and Cancer, 1989